These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 10690539

  • 1. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK, Mao L.
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [Abstract] [Full Text] [Related]

  • 2. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
    Sánchez-Céspedes M, Rosell R, Pifarré A, López-Cabrerizo MP, Barnadas A, Sánchez JJ, Lorenzo JC, Abad A, Monzó M, Navas-Palacios JJ.
    Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
    [Abstract] [Full Text] [Related]

  • 3. Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.
    Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.
    Cancer Res; 1999 Oct 01; 59(19):4798-803. PubMed ID: 10519387
    [Abstract] [Full Text] [Related]

  • 4. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT.
    Cancer Res; 2001 Jan 15; 61(2):612-5. PubMed ID: 11212258
    [Abstract] [Full Text] [Related]

  • 5. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC, Sasatomi E, Christie NA, Buenaventura PO, Finkelstein SD, Yousem SA, Soose R, Close JM, Luketich JD.
    J Thorac Cardiovasc Surg; 2004 Jan 15; 127(1):87-91. PubMed ID: 14752417
    [Abstract] [Full Text] [Related]

  • 6. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E, Finkelstein SD, Woods JD, Bakker A, Swalsky PA, Luketich JD, Fernando HC, Yousem SA.
    Cancer Res; 2002 May 01; 62(9):2681-9. PubMed ID: 11980668
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
    Carpagnano GE, Spanevello A, Carpagnano F, Palladino GP, Prato R, Martinelli D, Digioia G, Foschino-Barbaro MP.
    Lung Cancer; 2009 Jun 01; 64(3):334-40. PubMed ID: 18995925
    [Abstract] [Full Text] [Related]

  • 8. [Studies of microsatellite instability and loss of heterozygosity at chromosome 17 in non-small cell lung carcinoma].
    Guo X, Ni P, Li L.
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec 01; 22(12):743-5. PubMed ID: 11776784
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
    Tomizawa Y, Adachi J, Kohno T, Hamada K, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Yokota J.
    Clin Cancer Res; 1999 May 01; 5(5):1139-46. PubMed ID: 10353749
    [Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
    Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Sugio K, Yasumoto K, Sugimachi K, Gazdar AF.
    Clin Cancer Res; 1996 Jul 01; 2(7):1185-9. PubMed ID: 9816286
    [Abstract] [Full Text] [Related]

  • 11. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
    Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U.
    Clin Cancer Res; 1999 Oct 01; 5(10):2689-92. PubMed ID: 10537330
    [Abstract] [Full Text] [Related]

  • 12. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
    Hurr K, Kemp B, Silver SA, el-Naggar AK.
    Am J Pathol; 1996 Aug 01; 149(2):613-20. PubMed ID: 8701999
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
    Yoshino I, Osoegawa A, Yohena T, Kameyama T, Oki E, Oda S, Maehara Y.
    Respir Med; 2005 Mar 01; 99(3):308-12. PubMed ID: 15733506
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
    Maestro ML, Izquierdo L, Sánchez-Pernaute A, Sanz Casla MT, González S, Torres A, del Barco V, Gómez A, Pérez Aguirre E, Balibrea JL.
    Med Clin (Barc); 1999 Apr 24; 112(14):527-9. PubMed ID: 10363238
    [Abstract] [Full Text] [Related]

  • 15. [Lung cancer in women: clinical features and factors related to survival].
    Sen E, Kaya A, Erol S, Savas I, Gonullu U.
    Tuberk Toraks; 2008 Apr 24; 56(3):266-74. PubMed ID: 18932027
    [Abstract] [Full Text] [Related]

  • 16. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M.
    Int J Oncol; 2005 Aug 24; 27(2):481-8. PubMed ID: 16010431
    [Abstract] [Full Text] [Related]

  • 17. Frequency of loss of heterozygosity at 3 p, 9 p, 13 q, and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer.
    Haga Y, Hiroshima K, Iyoda A, Kohno H, Shibuya K, Iizasa T, Fujisawa T, Ohwada H.
    Thorac Cardiovasc Surg; 2005 Apr 24; 53(2):114-7. PubMed ID: 15786011
    [Abstract] [Full Text] [Related]

  • 18. p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma.
    Kohno H, Hiroshima K, Toyozaki T, Fujisawa T, Ohwada H.
    Cancer; 1999 Jan 15; 85(2):341-7. PubMed ID: 10023701
    [Abstract] [Full Text] [Related]

  • 19. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L, Khan MA, Freedman AN, Gemma A, Rusin M, Guinee DG, Bennett WP, Caporaso NE, Fleming MV, Travis WD, Colby TV, Trastek V, Pairolero PC, Tazelaar HD, Midthun DE, Liotta LA, Harris CC.
    Cancer Res; 1998 Jun 15; 58(12):2533-6. PubMed ID: 9635574
    [Abstract] [Full Text] [Related]

  • 20. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
    Wang J, Lu C, Liu XY, Zhang HB, Zhao J, Yang L, Guo QZ, An TT, Wu MN.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb 15; 30(2):103-7. PubMed ID: 17445470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.